Results 11 to 20 of about 2,670,869 (240)

Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma

open access: yesJournal of Hematology & Oncology, 2018
Background POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome still has no standard treatment. On the basis that both POEMS syndrome and myeloma have an underlying plasma cell dyscrasia, anti-myeloma ...
Jinhuan Xu   +14 more
doaj   +3 more sources

Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients. [PDF]

open access: yesTher Adv Neurol Disord
Background: Due to the rarity of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome, the best first-line treatment has not been established, although there are several options in guidelines.
Fang F   +9 more
europepmc   +2 more sources

POEMS Syndrome: 2019 Update on diagnosis, risk‐stratification, and management

open access: yesAmerican Journal of Hematology, 2019
Polyneuropathy, organomegaly, endocrinopathy, M‐protein, skin changes (POEMS) syndrome is a paraneoplastic syndrome due to an underlying plasma cell neoplasm.
A. Dispenzieri
semanticscholar   +3 more sources

Refractory ascites: unveiling POEMS syndrome as the underlying cause: a case report and literature review [PDF]

open access: yesFrontiers in Medicine
Ascites is a common clinical manifestation usually caused by portal hypertension, hypoalbuminemia, or malignant tumors; POEMS syndrome, a rare cause of ascites, can also lead to refractory ascites.
Shuang Liu   +9 more
doaj   +2 more sources

Poems Syndrome

open access: yesApollo Medicine, 2006
Naresh Kumar   +3 more
doaj   +4 more sources

Delayed diagnosis of POEMS syndrome, how AI tools can enhance diagnostic accuracy [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine
Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, and skin changes (POEMS) syndrome is a rare multisystem disorder often misdiagnosed due to its wide-ranging manifestations and clinical overlap with common medical conditions.
Max Jin   +4 more
doaj   +2 more sources

A case report of an M protein-negative patient with POEMS syndrome associated with renal involvement [PDF]

open access: yesBMC Nephrology
Background POEMS syndrome with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes is an uncommon plasma cell paraneoplastic syndrome involving multiple system.
Wenlin Liu   +5 more
doaj   +2 more sources

Association of co-existing vitamin B6 and B12 deficiency with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome: a case report [PDF]

open access: yesBMC Neurology
Background Both vitamin B6 deficiency and vitamin B12 deficiency can present with symptoms that appear like polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome, with painful peripheral neuropathy and sensorimotor ...
Stephan Hu   +3 more
doaj   +2 more sources

[Chinese expert consensus on the diagnosis and treatment of POEMS syndrome (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group   +3 more
europepmc   +2 more sources

Neurological Peculiarities of POEMS Syndrome: Experience From a Brazilian University Center. [PDF]

open access: yesMuscle Nerve
ABSTRACT Aim Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes (POEMS) syndrome is a rare paraneoplastic syndrome associated with significant neurologic morbidity. Better understanding of the manifestations of this disease is crucial to early diagnosis and improvement of prognosis.
Rosenstein RF   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy